Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Unprecedented Behavior of (9 R)-9-Hydroxystearic Acid-Loaded Keratin Nanoparticles on Cancer Cell Cycle.

Busi A, Aluigi A, Guerrini A, Boga C, Sartor G, Calonghi N, Sotgiu G, Posati T, Corticelli F, Fiori J, Varchi G, Ferroni C.

Mol Pharm. 2019 Mar 4;16(3):931-942. doi: 10.1021/acs.molpharmaceut.8b00827. Epub 2019 Feb 14.

PMID:
30702899
3.

Comparative efficacy in red blood cell exchange transfusions with different apheresis machines in patients with sickle cell disease.

Buyukkurt N, Kozanoğlu I, Korur AP, Asma S, Yeral M, Solmaz S, Kandemir F, Gereklioglu C, Sariturk C, Boga C, Ozdogu H.

Indian J Hematol Blood Transfus. 2018 Jul;34(3):495-500. doi: 10.1007/s12288-017-0898-5. Epub 2017 Nov 7.

PMID:
30127560
4.

Demodicidosis Accompanying Acute Cutaneous Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation

Aytan P, Yeral M, Gereklioğlu Ç, Koçer NE, Büyükkurt N, Kozanoğlu İ, Özdoğu H, Boğa C.

Turk J Haematol. 2018 Nov 13;35(4):313-314. doi: 10.4274/tjh.2018.0057. Epub 2018 Jul 2. No abstract available.

5.

(9R)-9-Hydroxystearate-Functionalized Anticancer Ceramics Promote Loading of Silver Nanoparticles.

Boanini E, Cassani MC, Rubini K, Boga C, Bigi A.

Nanomaterials (Basel). 2018 May 31;8(6). pii: E390. doi: 10.3390/nano8060390.

6.

Problems With Unrelated Donors For Stem Cell Transplant and Proposed Solutions: A Single-Center Experience.

Kozanoglu I, Ozdogu H, Asma S, Yeral M, Atar S, Tepebasi S, Has Cuhadar M, Ozturk M, Boga C.

Exp Clin Transplant. 2018 May 23. doi: 10.6002/ect.2018.0059. [Epub ahead of print] No abstract available.

7.

Frequency of Finding Family Donors: A Single Center Experience.

Kasar M, Yeral M, Solmaz S, Büyükkurt N, Asma S, Gereklioğlu Ç, Boğa C, Özdoğu H, Baştürk B.

Exp Clin Transplant. 2018 Mar;16 Suppl 1(Suppl 1):47-50. doi: 10.6002/ect.TOND-TDTD2017.O20.

8.

Effects of two doses of anti-T lymphocyte globulin-Fresenius given after full-match sibling stem cell transplantation in acute myeloblastic leukemia patients who underwent myeloablative fludarabine/busulfan conditioning.

Boga C, Yeral M, Gereklioglu C, Asma S, Maytalman E, Aytan P, Kozanoglu I, Sariturk C, Ozdogu H.

Hematol Oncol Stem Cell Ther. 2018 Sep;11(3):149-157. doi: 10.1016/j.hemonc.2018.01.004. Epub 2018 Feb 20.

9.

Organ damage mitigation with the Baskent Sickle Cell Medical Care Development Program (BASCARE).

Ozdogu H, Boga C, Asma S, Kozanoglu I, Gereklioglu C, Yeral M, Buyukkurt NT, Solmaz S, Korur A, Aytan P, Maytalman E, Kasar M.

Medicine (Baltimore). 2018 Feb;97(6):e9844. doi: 10.1097/MD.0000000000009844.

10.

Allogenic peripheral stem cell transplantation from HLA-matched related donors for adult sickle cell disease: remarkable outcomes from a single-center trial.

Ozdogu H, Boga C, Yeral M, Kozanoglu I, Gereklioglu C, Aytan P, Kasar M, Asma S, Buyukkurt N, Solmaz S, Korur A, Sariturk C.

Bone Marrow Transplant. 2018 Jul;53(7):880-890. doi: 10.1038/s41409-018-0111-y. Epub 2018 Feb 5.

PMID:
29403023
11.

Use of Plerixafor to Mobilize a Healthy Donor Infected with Influenza A.

Yeral M, Aytan P, Boğa C.

Turk J Haematol. 2018 May 25;35(2):138-139. doi: 10.4274/tjh.2017.0304. Epub 2018 Feb 2. No abstract available.

12.

Regioselectivity in Reactions between Bis(2-benzothiazolyl)ketone and Vinyl Grignard Reagents: C- versus O-alkylation-Part III.

Boga C, Bordoni S, Casarin L, Micheletti G, Monari M.

Molecules. 2018 Jan 15;23(1). pii: E171. doi: 10.3390/molecules23010171.

13.

Corticosteroid-induced vaso-occlusive events may be prevented by lowering hemoglobin S levels in adults with sickle cell disease.

Yeral M, Boga C, Aytan P, Ozdogu H.

Transfus Apher Sci. 2017 Oct;56(5):717-718. doi: 10.1016/j.transci.2017.08.005. Epub 2017 Sep 2. No abstract available.

PMID:
28988593
14.

Significance of electronic health records: A comparative study of vaccination rates in patients with sickle cell disease.

Korur A, Asma S, Gereklioglu C, Solmaz S, Boga C, Ozsahin AK, Kut A.

Pak J Med Sci. 2017 May-Jun;33(3):549-553. doi: 10.12669/pjms.333.12837.

15.

Quantum cell expansion system: Safe and rapid expansion.

Kozanoglu I, Maytalman E, Gereklioglu C, Yeral M, Buyukkurt N, Aytan P, Boga C, Ozdogu H.

Cytotherapy. 2017 Oct;19(10):1246-1247. doi: 10.1016/j.jcyt.2017.07.004. Epub 2017 Aug 10. No abstract available.

PMID:
28803897
16.

Granulocyte-colony stimulating factor administration among hemoglobin S trait donors: A single center experience from the Eastern Mediterranean region.

Gereklioglu C, Asma S, Korur A, Tepebaşı S, Aytan P, Yeral M, Kozanoglu I, Boga C, Ozdogu H.

J Clin Apher. 2018 Feb;33(1):65-71. doi: 10.1002/jca.21566. Epub 2017 Jul 12.

PMID:
28699692
17.

JACIE accreditation from the perspective of an accredited centre.

Boga C, Kozanoglu I.

Bone Marrow Transplant. 2017 Sep;52(9):1352. doi: 10.1038/bmt.2017.149. Epub 2017 Jul 10. No abstract available.

PMID:
28692027
18.

C-C Coupling Reactions between Benzofurazan Derivatives and 1,3-Diaminobenzenes.

Micheletti G, Bordoni S, Chugunova E, Boga C.

Molecules. 2017 Apr 26;22(5). pii: E684. doi: 10.3390/molecules22050684.

19.

Implementation of an ISBT 128-Compatible Medical Record System to Facilitate Traceability of Stem Cell Products.

Boğa C, Maytalman E, Gereklioğlu Ç, Asma S, Kandemir F, Aytan P, Korur A, Yeral M, Kozanoğlu İ, Özdoğu H.

Turk J Haematol. 2017 Aug 2;34(3):280-281. doi: 10.4274/tjh.2017.0081. Epub 2017 Apr 26. No abstract available.

20.

An Unusual Giant Leg Ulcer as a Rare Presentation of Sweet's Syndrome in a Patient with Hairy Cell Leukemia Successfully Managed by Splenectomy.

Özdoğu H, Yeral M, Boğa C.

Turk J Haematol. 2017 Aug 2;34(3):270-271. doi: 10.4274/tjh.2016.0416. Epub 2017 Mar 8. No abstract available.

21.

Is the Game Over or Starting Again? The Role of the Transplant Team in Genetic Counseling for Adult Sickle Cell Disease Recipients.

Aytan P, Gereklioğlu Ç, Yeral M, Korur A, Asma S, Kozanoğlu İ, Özdoğu H, Boğa C.

Turk J Haematol. 2017 Jun 5;34(2):196-197. doi: 10.4274/tjh.2016.0355. Epub 2016 Dec 12. No abstract available.

22.

QTc prolongation during peripheral stem cell apheresis in healthy volunteers.

Korur A, Kozanoglu I, Buyukkurt N, Yeral M, Kandemir F, Gereklioglu C, Sariturk C, Asma S, Solmaz S, Boga C, Ozdogu H.

J Clin Apher. 2017 Aug;32(4):240-245. doi: 10.1002/jca.21504. Epub 2016 Aug 20.

PMID:
27543914
23.

Effectiveness of Visual Methods in Information Procedures for Stem Cell Recipients and Donors.

Sarıtürk Ç, Gereklioğlu Ç, Korur A, Asma S, Yeral M, Solmaz S, Büyükkurt N, Tepebaşı S, Kozanoğlu İ, Boğa C, Özdoğu H.

Turk J Haematol. 2017 Dec 1;34(4):321-327. doi: 10.4274/tjh.2016.0118. Epub 2016 Jul 15.

24.

Development of Acute Promyelocytic Leukemia in a Patient With Gouty Arthritis on Long Term Colchicine.

Buyukkurt N, Korur A, Boga C.

Indian J Hematol Blood Transfus. 2016 Jun;32(Suppl 1):80-1. doi: 10.1007/s12288-015-0523-4. Epub 2015 Apr 9.

25.

New azo-decorated N-pyrrolidinylthiazoles: synthesis, properties and an unexpected remote substituent effect transmission.

Boga C, Cino S, Micheletti G, Padovan D, Prati L, Mazzanti A, Zanna N.

Org Biomol Chem. 2016 Aug 7;14(29):7061-8. doi: 10.1039/c6ob00994h. Epub 2016 Jul 4.

PMID:
27376825
26.

Effect of Hereditary Hemochromatosis Gene H63D and C282Y Mutations on Iron Overload in Sickle Cell Disease Patients.

Terzi YK, Bulakbaşı Balcı T, Boğa C, Koç Z, Yılmaz Çelik Z, Özdoğu H, Karakuş S, Şahin Fİ.

Turk J Haematol. 2016 Dec 1;33(4):320-325. doi: 10.4274/tjh.2015.0254. Epub 2016 Apr 18.

27.

C-C coupling between trinitrothiophenes and triaminobenzenes: zwitterionic intermediates and new all-conjugated structures.

Boga C, Micheletti G, Cino S, Fazzini S, Forlani L, Zanna N, Spinelli D.

Org Biomol Chem. 2016 May 4;14(18):4267-75. doi: 10.1039/c6ob00243a.

PMID:
27075703
28.

East Mediterranean region sickle cell disease mortality trial: retrospective multicenter cohort analysis of 735 patients.

Karacaoglu PK, Asma S, Korur A, Solmaz S, Buyukkurt NT, Gereklioglu C, Kasar M, Ozbalcı D, Unal S, Kaya H, Gurkan E, Yeral M, Sariturk Ç, Boga C, Ozdogu H.

Ann Hematol. 2016 May;95(6):993-1000. doi: 10.1007/s00277-016-2655-5. Epub 2016 Apr 12.

PMID:
27068408
29.

Active Invasive Fungal Infection in a Patient With Severe Aplastic Anemia.

Solmaz S, Korur A, Yeral M, Gereklioglu C, Ulusan SN, Boga C, Ozdogu H.

Exp Clin Transplant. 2016 Apr 7. doi: 10.6002/ect.2015.0307. [Epub ahead of print]

30.

Anorectal Complications During Neutropenic Period in Patients with Hematologic Diseases.

Solmaz S, Korur A, Gereklioğlu Ç, Asma S, Büyükkurt N, Kasar M, Yeral M, Kozanoğlu İ, Boğa C, Ozdoğu H.

Mediterr J Hematol Infect Dis. 2016 Mar 1;8(1):e2016019. doi: 10.4084/MJHID.2016.019. eCollection 2016.

31.

Pregnancy and sickle cell disease: A review of the current literature.

Boga C, Ozdogu H.

Crit Rev Oncol Hematol. 2016 Feb;98:364-74. doi: 10.1016/j.critrevonc.2015.11.018. Epub 2015 Nov 27. Review.

PMID:
26672916
32.

(9R)-9-Hydroxystearate-Functionalized Hydroxyapatite as Antiproliferative and Cytotoxic Agent toward Osteosarcoma Cells.

Boanini E, Torricelli P, Boga C, Micheletti G, Cassani MC, Fini M, Bigi A.

Langmuir. 2016 Jan 12;32(1):188-94. doi: 10.1021/acs.langmuir.5b03754. Epub 2015 Dec 21.

PMID:
26646551
33.

Tacrolimus-Induced Diabetic Ketoacidosis After Allogeneic Bone Marrow Transplant.

Solmaz S, Gökgöz Z, Gereklioğlu Ç, Yeral M, Boğa C, Özdoğu H.

Exp Clin Transplant. 2017 Dec;15(6):702-703. doi: 10.6002/ect.2015.0047. Epub 2015 Dec 1.

34.

New electron-donor and -acceptor architectures from benzofurazans and sym-triaminobenzenes: intermediates, products and an unusual nitro group shift.

Micheletti G, Boga C, Pafundi M, Pollicino S, Zanna N.

Org Biomol Chem. 2016 Jan 14;14(2):768-776. doi: 10.1039/c5ob02180d.

PMID:
26593383
35.

Recommendations for Risk Categorization and Prophylaxis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Expert Opinion (TEO-4).

Boğa C, Bolaman Z, Çağırgan S, Karadoğan İ, Özcan MA, Özkalemkaş F, Saba R, Sönmez M, Şenol E, Akan H, Akova M.

Turk J Haematol. 2015 Jun;32(2):100-17. doi: 10.4274/tjh.2014.0277. Review.

36.

Clinical Relevance of Apheretic Graft Composition in Patients With Acute Myeloblastic Leukemia Who Received a Busulfan-Fludarabine-Antithymocyte Globulin Conditioning Regimen for Allogeneic Transplant.

Yeral M, Kasar M, Boga C, Kozanoglu I, Ozdogu H, Sariturk C.

Exp Clin Transplant. 2015 Oct;13(5):453-60. doi: 10.6002/ect.2014.0223. Epub 2015 Jun 15.

37.

Effectiveness of fludarabine- and busulfan-based conditioning regimens in patients with acute myeloblastic leukemia: 8-year experience in a single center.

Kasar M, Asma S, Kozanoglu I, Maytalman E, Boga C, Ozdogu H, Yeral M.

Transplant Proc. 2015 May;47(4):1217-21. doi: 10.1016/j.transproceed.2014.10.059.

PMID:
26036558
38.

A Rare Complication Developing After Hematopoietic Stem Cell Transplantation: Wernicke's Encephalopathy.

Solmaz S, Gereklioğlu Ç, Tan M, Demir Ş, Yeral M, Korur A, Boğa C, Özdoğu H.

Turk J Haematol. 2015 Dec;32(4):367-70. doi: 10.4274/tjh.2014.0412. Epub 2015 Apr 27.

39.

Hematopoietic Stem Cell Transplantation in Adult Sickle Cell Disease: Problems and Solutions.

Özdoğu H, Boğa C.

Turk J Haematol. 2015 Sep;32(3):195-205. Review.

40.

Cobalamin deficiency can mask depleted body iron reserves.

Solmaz S, Özdoğu H, Boğa C.

Indian J Hematol Blood Transfus. 2015 Jun;31(2):255-8. doi: 10.1007/s12288-014-0417-x. Epub 2014 Jun 14.

41.

Tunnelled central venous catheter-related problems in the early phase of haematopoietic stem cell transplantation and effects on transplant outcome.

Yeral M, Boğa C, Oğuzkurt L, Alışkan HE, Özdoğu H, Demiroğlu YZ.

Turk J Haematol. 2015 Mar 5;32(1):51-7. doi: 10.4274/tjh.2013.0278.

42.

Synthesis and antimicrobial activity of novel structural hybrids of benzofuroxan and benzothiazole derivatives.

Chugunova E, Boga C, Sazykin I, Cino S, Micheletti G, Mazzanti A, Sazykina M, Burilov A, Khmelevtsova L, Kostina N.

Eur J Med Chem. 2015 Mar 26;93:349-59. doi: 10.1016/j.ejmech.2015.02.023. Epub 2015 Feb 17.

PMID:
25707015
43.

Ring closure of azo compounds to 1,2-annulated benzimidazole derivatives and further evidence of reversibility of the azo-coupling reaction.

Del Vecchio E, Boga C, Forlani L, Tozzi S, Micheletti G, Cino S.

J Org Chem. 2015 Feb 20;80(4):2216-22. doi: 10.1021/jo5027244. Epub 2015 Feb 3.

PMID:
25615685
44.

Prophylactic red blood cell exchange may be beneficial in the management of sickle cell disease in pregnancy.

Asma S, Kozanoglu I, Tarım E, Sarıturk C, Gereklioglu C, Akdeniz A, Kasar M, Turgut NH, Yeral M, Kandemir F, Boga C, Ozdogu H.

Transfusion. 2015 Jan;55(1):36-44. doi: 10.1111/trf.12780. Epub 2014 Jul 29.

PMID:
25070465
45.

Use of mesenchymal cells to modulate immune suppression and immune reconstruction in a patient with aplastic anemia complicated by invasive sino-orbital aspergillosis.

Ozdoğu H, Yeral M, Boğa C, Kozanoğlu I.

Turk J Haematol. 2014 Jun;31(2):181-3. doi: 10.4274/tjh.2013.0041. Epub 2014 Jun 10.

46.

Formaldehyde replacement with glyoxylic acid in semipermanent hair straightening: a new and multidisciplinary investigation.

Boga C, Taddei P, Micheletti G, Ascari F, Ballarin B, Morigi M, Galli S.

Int J Cosmet Sci. 2014 Oct;36(5):459-70. doi: 10.1111/ics.12148. Epub 2014 Aug 11.

PMID:
24962464
47.

Therapeutic potential of apigenin, a plant flavonoid, for imatinib-sensitive and resistant chronic myeloid leukemia cells.

Solmaz S, Adan Gokbulut A, Cincin B, Ozdogu H, Boga C, Cakmakoglu B, Kozanoglu I, Baran Y.

Nutr Cancer. 2014;66(4):599-612. doi: 10.1080/01635581.2014.894099. Epub 2014 Mar 26.

PMID:
24669768
48.

Clinical significance of circulating blood and endothelial cell microparticles in sickle-cell disease.

Kasar M, Boğa C, Yeral M, Asma S, Kozanoglu I, Ozdogu H.

J Thromb Thrombolysis. 2014;38(2):167-75. doi: 10.1007/s11239-013-1028-3.

PMID:
24254379
49.

Plasma-exchange treatment for severe carbamazepine intoxication: a case study.

Kozanoglu I, Kahveci S, Asma S, Yeral M, Noyan A, Boga C, Ozdogu H.

J Clin Apher. 2014 Jun;29(3):178-80. doi: 10.1002/jca.21305. Epub 2013 Oct 18.

PMID:
24136443
50.

Short-term central venous catheter complications in patients with sickle cell disease who undergo apheresis.

Yeral M, Boga C, Oguzkurt L, Asma S, Kasar M, Kozanoglu I.

J Thromb Thrombolysis. 2014;37(2):97-101. doi: 10.1007/s11239-013-0914-z.

PMID:
23504572

Supplemental Content

Support Center